Related Experiment Video
Updated: Aug 6, 2026

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
Abnormal ClC-3/TMEM9-mediated endosomal ion transport in CLCN3-associated neurodevelopmental disease
Maya M Polovitskaya1,2, Tinatin Tkemaladze3,4, Lotte Jensen5
1Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Insights
Genetic variants in CLCN3, encoding a chloride/proton exchanger, cause neuropsychiatric disorders. These mutations lead to altered ion transport and endolysosomal abnormalities, revealing a toxic gain-of-function mechanism.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Endolysosomal abnormalities are linked to neurological and psychiatric conditions.
- Chloride channel ClC-3 (encoded by CLCN3) is crucial for maintaining ion homeostasis in endosomes and lysosomes.
- Dysfunction of CLC exchangers can disrupt neuronal function.
Purpose of the Study:
- To investigate the genetic and clinical spectrum of CLCN3-related disorders.
- To elucidate the pathogenic mechanisms of CLCN3 variants.
- To understand the regulation of ClC-3 by the TMEM9 beta subunit.
Main Methods:
- Clinical evaluation of 20 individuals with CLCN3 variants.
- Functional characterization of ClC-3 variants in ion transport.
- Investigation of TMEM9-mediated inhibition of ClC-3.
- Assessment of endolysosomal morphology in cells expressing mutant ClC-3/TMEM9.
Main Results:
- 15 new individuals with CLCN3 variants were identified, exhibiting diverse neuropsychiatric symptoms like developmental delay, intellectual disability, and epilepsy.
- 12 of 20 missense variants showed altered ion transport properties.
- Variants were classified based on their impact on TMEM9 binding or ion conduction properties.
- Mutant ClC-3/TMEM9 overexpression induced endolysosomal vacuolization, indicating a toxic gain-of-function.
Conclusions:
- CLCN3 variants represent a significant genetic cause of neuropsychiatric disorders.
- Altered ClC-3 ion transport and impaired TMEM9 regulation contribute to disease pathogenesis.
- The study reveals a novel connection between channel gating and TMEM9 inhibition, impacting endolysosomal function.
Abstract:
Endolysosomal abnormalities are particularly detrimental to the nervous system and have been implicated in neuropsychiatric disorders. Key regulators of the lysosomal and endosomal luminal ion homeostasis are CLC chloride/proton exchangers. We report 15 individuals carrying variants in CLCN3, encoding a ubiquitous endosomal 2Cl-/H+ exchanger, and provide updated clinical information for 5 previously reported individuals. Subjects displayed a broad spectrum of neuropsychiatric symptoms, including developmental delay, intellectual disability, and epilepsy. To reveal the pathogenic mechanism, we investigated ClC-3 variants-mediated ion transport and its regulation by the recently discovered inhibitory beta subunit TMEM9. 12/20 missense variants exhibited altered properties and fell into two classes: those affecting the region binding inhibitory TMEM9 carboxy-termini, and those that broaden the voltage range over which ClC-3 conducts ions. Surprisingly, the latter variants also attenuated TMEM9-mediated inhibition. Both classes produced a toxic gain-of-function, as evident from endolysosomal vacuolization by mutant ClC-3/TMEM9 overexpression. Our results expand the genetic and clinical spectrum of CLCN3-related disease, provide a solid basis for genetic counseling, and uncover an unexpected link between gating-associated conformational changes and inhibition by TMEM9.
Related Concept Videos
The Early Endosome: Endocytosis of Transferrin
Lysosomal Hydrolases
Clathrin Coated Vesicles
Vesicular Tubular Clusters
With the help of motor proteins such...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Facilitated Transport
